Investments In Health And Emerging Markets Will Unlock Long-Term Value

AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Published
08 Aug 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$90.35
26.8% undervalued intrinsic discount
06 Aug
US$66.16
Loading
1Y
-29.8%
7D
-7.8%

Author's Valuation

US$90.4

26.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 2.01%

Shared on30 Apr 25
Fair value Decreased 0.39%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 1.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 2.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 7.60%

Shared on02 Apr 25
Fair value Decreased 0.56%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 9.16%

AnalystConsensusTarget has decreased revenue growth from 0.4% to -0.8%.